NICE propose to charge £142,000 to conduct single technology appraisals from May 2017.
Read more HERE
Articles
NICE propose to charge £142,000 to conduct single technology appraisals from May 2017.
Read more HERE
We discuss the 2024 VPAG agreement, how it differs from the previous VPAS and whether this will impa...
Read moreWebinar: Discussions on the new Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch